Navigation Links
Mastix Medica Introduces RenaGum™ - The First Medical Food Chewing Gum
Date:8/8/2013

Hunt Valley, MD (PRWEB) August 08, 2013

Mastix Medica, an innovative specialty manufacturer of dietary supplements and functional foods, has introduced RenaGum™, a novel medical food that helps patients with chronic kidney disease (CKD) maintain normal phosphate levels. RenaGum™ is specially formulated with chitosan, a well-known dietary, medical and environmental binding agent. Clinical studies show that chitosan released from chewing gum is an effective way to help maintain normal serum phosphate levels in CKD patients. RenaGum™ is made using natural ingredients, a non-allergenic chitosan from a vegetable source, not from shellfish, and is also Kosher certified. As a medical food product, RenaGum™ needs to be used under the supervision of a physician.

CKD is a growing health problem in the United States, with at least 20 million people in various stages of CKD including about 500,000 people with end-stage renal disease (ESRD) requiring hemodialysis. The two main causes of CKD are diabetes and high blood pressure accounting for up to 2/3 of all CKD cases. In people with CKD, and especially people with ESRD, one of the most important co-existing disorders is caused by increased levels of phosphorus (hyperphosphatemia) in the body.

Elevated serum phosphate levels are significantly associated with cardiovascular calcification and increased cardiac mortality. People with CKD and ESRD need to watch what they eat and drink and may take phosphate binder drugs that their doctor prescribes. These phosphate binder drugs are taken by patients during meals to prevent the absorption of phosphate in the digestive system from the food that is consumed.

“We are excited that Mastix Medica is introducing its first proprietary product, RenaGum™, to help people with CKD and ESRD maintain healthy phosphate levels,” commented Robert Estey, CEO of Mastix Medica. “RenaGum™ is a complimentary medical food that is chewed after a meal. It is designed to work with and complement a patient’s prescribed binder drugs at a different time and in a different way,” he continued. “RenaGum™ is not a replacement for a patient’s prescribed binder drugs. When the gum is chewed, the chitosan combines with phosphate found in saliva and then in the digestive tract after the saliva is swallowed,” Estey stated. “We expect RenaGum™ to become an integral component of the dietary management of kidney disease in patients with CKD and ESRD. Patients also like RenaGum™ because, as a chewing gum, it does not add to the heavy pill burden they already take with their meals,” concluded Mr. Estey.

More information about RenaGum™ can be found at http://www.renagum.com.

About Medical Foods
A Medical Food is an FDA-regulated product defined by Congress as part of the Orphan Drug Act. A Medical Food is specially formulated to be administered orally under the supervision of a physician and is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation. Medical Foods have clinical studies supporting their use for specific conditions due to nutritional imbalances or deficiencies. Medical Foods are made with ingredients that are Generally Recognized As Safe (GRAS), the highest FDA standard of safety given to foods.

About Mastix Medica
Mastix Medica is a specialty manufacturer with expertise in unique tableted dosage forms like tableted chewing gum, lozenges and chewable tablets. Mastix Medica has a proprietary tableted gum manufacturing process that is unique in the industry. With a history in candy manufacturing, Mastix Medica has broad custom product development capabilities that have expanded into functional foods and dietary supplements, with particular expertise in hard to formulate tablet products, direct compression chewing gum and taste masking.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11010469.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. California Physical Therapy Association Strongly Supports the "Promoting Integrity in Medicare Act" to Fight Self-Referral of Physical Therapist Services
2. China Medical Flat Panel Detector Market & Pressure Injector 2013 Research Reports Now Available at ReportsnReports.com
3. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
4. Emerging Global Leader in Emergency Thermotherapy for Traumatic Brain Injury Expands US Operations to Site on the Campus of New York Medical College
5. Top Drug Testing Kit Distributor, Medical Disposables Corp. Joins the Florida Staffing Association
6. National Reference Laboratory, Warde Medical Laboratory to Showcase at 2013 AACC Clinical Lab Expo
7. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
8. Saladax Biomedical Announces Addition to Leadership Team
9. Medical Device and Drug Research, New Life Science Webinar Hosted by Xtalks
10. Medical Power Supply Market Worth $866.8 Million By 2017
11. Tutela Launches Genesis II - Next Generation Wireless Medical Monitoring System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , ... January 20, 2017 ... ... Less Exposure Surgery (LES®) Technologies, announced today the next evolution in spinal ... Screw System platform). In contrast to the competition, SpineFrontier is focused on ...
(Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
(Date:1/19/2017)... -- Market Research Future has a half cooked research report on Global ... rapidly and expected to reach USD 450 Million by the end ... ... been assessed as a swiftly growing market and expected that the ... future. There has been a tremendous growth in the prevalence of ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 /PRNewswire/ ... the formation of its Medical/Clinical Advisory Board.  This ... veterans who enhance the range and depth of ... of its novel prenatal diagnostic tests.  These experts ... strategic guidance for the company,s product development and ...
Breaking Biology Technology:
(Date:1/19/2017)... PUNE, India , January 19, 2017 According to ... Market, Opportunities and Forecast, 2014 - 2022," the global biometric sensor market is ... from 2016 to 2022. In 2015, Asia-Pacific dominated the ... public and private sectors. Continue Reading ... ...
(Date:1/19/2017)... , Jan. 19, 2017 Sensory ... experience and security for consumer electronics, and ... processing systems and cybersecurity solutions, today announced a ... and financial institutions worldwide to bolster security of ... end-to-end secure user authentication platforms they offer, innerCore ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):